A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

• Status: Completed
• Trial end date: 2021-10-12
• Target enrollment: 0
• Participant gender: Female

Summary

The primary objective of this study is to assess the efficacy of a levonorgestrel-releasing intrauterine system (LNG20) in nulliparous and parous females of child-bearing potential who request long-term, reversible contraception for up to 10 years.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Medicines360
• Treatments: Levonorgestrel

Criteria

Inclusion Criteria:

• Healthy women requesting contraception

• 16-35 years old

• Cohort 36-45 years old

• Sexually active

Exclusion Criteria:

• Currently pregnant, pregnant within 4 weeks prior to study entry or planning pregnancy within 24 months of study entry

• Currently breastfeeding

• Current persistent, abnormal vaginal bleeding